large_pharma
GILEAD SCIENCES
Sponsor view across the ADC target screen, including linked targets and source-linked trial evidence.
ADC target activity
Tracked targets
| Target | Trial count | Evidence |
|---|---|---|
| TROP2 / TACSTD2 | 1 | Source |
Linked trials
Clinical evidence links
- NCTADC002: Sacituzumab Govitecan in Metastatic Triple Negative Breast Cancer (ACTIVE_NOT_RECRUITING)